Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Clinical Cancer Research|2022Cited by 22
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNAAriana Huebner, Rodrigo A. Toledo, James R. Black et al.|Genome Medicine|2023Cited by 8
Data from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Unknown|2023Cited by 0
Data from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Unknown|2023Cited by 0